Biancani. Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles. Am J Physiol Cell Physiol 287: C384 -C394, 2004; 10.1152/ajpcell.00390.2003.-Contraction of smooth muscle depends on the balance of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities. Because MLCK activation depends on the activation of calmodulin, which requires a high Ca 2ϩ concentration, phosphatase inhibition has been invoked to explain contraction at low cytosolic Ca 2ϩ levels. The link between activation of the Ca 2ϩ -independent protein kinase C⑀ (PKC⑀) and MLC phosphorylation observed in the esophagus (ESO) (Sohn UD, Cao W, Tang DC, Stull JT, Haeberle JR, Wang CLA, Harnett KM, Behar J, and Biancani P. Am J Physiol Gastrointest Liver Physiol 281: G467-G478, 2001), however, has not been elucidated. We used phosphatase and kinase inhibitors and antibodies to signaling enzymes in combination with intact and saponin-permeabilized isolated smooth muscle cells from ESO and lower esophageal sphincter (LES) to examine PKC⑀-dependent, Ca 2ϩ -independent signaling in ESO. The phosphatase inhibitors okadaic acid and microcystin-LR, as well as an antibody to the catalytic subunit of type 1 protein serine/threonine phosphatase, elicited similar contractions in ESO and LES. MLCK inhibitors (ML-7, ML-9, and SM-1) and antibodies to MLCK inhibited contraction induced by phosphatase inhibition in LES but not in ESO. The PKC inhibitor chelerythrine and antibodies to PKC⑀, but not antibodies to PKCII, inhibited contraction of ESO but not of LES. In ESO, okadaic acid triggered translocation of PKC⑀ from cytosolic to particulate fraction and increased activity of integrin-linked kinase (ILK). Antibodies to the mitogen-activated protein (MAP) kinases ERK1/ERK2 and to ILK, and the MAP kinase kinase (MEK) inhibitor PD-98059, inhibited okadaic acid-induced ILK activity and contraction of ESO. We conclude that phosphatase inhibition potentiates the effects of MLCK in LES but not in ESO. Contraction of ESO is mediated by activation of PKC⑀, MEK, ERK1/2, and ILK. protein kinase C; myosin light chain kinase; phosphatase; integrinlinked kinase SMOOTH MUSCLE CONTRACTION is regulated primarily by the reversible phosphorylation of myosin (1, 27, 58), depending on the balance between myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities, and both enzymes are subject to regulation. Most contractile stimuli elicit an increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) via entry of Ca 2ϩ from the extracellular space and/or release from intracellular stores, whereupon Ca 2ϩ activates calmodulin (CaM)-dependent MLCK. Activated MLCK phosphorylates the 20-kDa myosin light chains (MLC) of myosin II at Ser 19 to activate cross-bridge cycling and the development of force or shortening of the muscle. Relaxation generally follows removal of the stimulus, whereupon [Ca 2ϩ ] i returns to resting levels as Ca 2ϩ is removed from the cytosol. MLCK (32) is i...